Get all premium features to the best stock analysis tool

Finranks

Finranks

Company

  • About us

Contact us

  • [email protected]

Follow us

  • Instagram
  • Telegram
  • LinkedIn

All rights reserved.

Privacy PolicyTerms of Conditions
  • Home
  • Markets
  • Screener
  • News
  • About
  1. Home
  3. PBYI

(PBYI)

NMS – Real Time Price. Currency in USD

6.08

-0.19 (-3.03%)

At close: Mar 27, 2026, 4:00 PM EDT

6.08

0.00 (0.00%)

After-hours: Mar 27, 2026, 6:08 PM EDT

  • Summary
  • News
  • Chart
  • Financial
  • Dividends
  • Forecast
  • Ownership
  • Profile
Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why
18.03.2026

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

PBYI stock drops over 9% as weak 2026 revenue guidance and heavy reliance on Nerlynx raise concerns despite modest sales growth.

IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?
12.03.2026

IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?

Ironwood and Puma Biotechnology are developing GI and cancer therapies, respectively, with sales of their sole drugs expected to support 2026 revenues.

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View
27.02.2026

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

Puma Biotechnology Q4 earnings top estimates with 28% revenue jump, but weak 2026 outlook sparks 14% after-hours plunge.

Puma Biotechnology, Inc. (PBYI) Q4 2025 Earnings Call Transcript
27.02.2026

Puma Biotechnology, Inc. (PBYI) Q4 2025 Earnings Call Transcript

Puma Biotechnology, Inc. (PBYI) Q4 2025 Earnings Call Transcript

Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates
27.02.2026

Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates

Puma Biotech (PBYI) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.43 per share a year ago.

Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results
26.02.2026

Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology issued its 4Q-2025 earnings release on Feb. 26 and followed with a conference call to review results.

Puma Biotechnology to Present at TD Cowen's 46th Annual Health Care Conference
23.02.2026

Puma Biotechnology to Present at TD Cowen's 46th Annual Health Care Conference

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology CEO & President Alan Auerbach will provide a corporate overview at the TD Cowen Health Care Conference on March 2 at 2:30 pm ET.

Videos

No Data

There is no data to display